Dr. Marc Mittelman is a principal with the consulting firm Mittelman and Associates. He has over 35 years’ experience in academia, industry, and technology consulting.  He is an inventor, and has been a founding partner of three medical device and biotechnology companies. The majority of his research and consulting work has involved microbiological challenges in pharmaceutical/biotechnology, medical device, clinical, and industrial applications.

 

Dr. Mittelman has developed test systems and analytical methods for monitoring biofilm development on engineered materials, and has conducted a number of studies on the contamination of critical components from the International Space Station for NASA.  He provides consulting services in the fields of biological fouling (biofouling), microbially influenced corrosion (MIC), purified/drinking water system contamination control, medical device–related infections, and antimicrobial coatings development.  Dr. Mittelman has conducted contamination control investigations for industrial and biopharmaceutical applications, focusing on process- and product-compatible solutions.  He has designed preventative and remedial strategies for controlling microbiological contamination in products and process operations ranging from high purity water systems to marine structures.  He has also provided new product development support to large and small medical device companies, with a focus on biofilm prevention and infection control strategies.

 

Dr. Mittelman was previously an Associate Professor in the Faculties of Medicine and Dentistry, and director of the Centre for Infection and Biomaterials Research (CIBR), at the University of Toronto. He was also a visiting scientist at Harvard University, School of Engineering and Applied Sciences.  He has worked as a microbiologist in the pharmaceutical industry, directed microbiology and medical device engineering consulting practices, and has served as an expert witness in in several legal cases.  Dr. Mittelman was co-chair of the Bioburden Task Force Committee for the Parenteral Drug Association.  Dr. Mittelman is the author of over 85 scientific papers and books, and has lectured extensively on microbiological contamination control.